The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients

Background: Lead poisoning was on the rise in recent years. There exists a lack of easy access to some of the main chelator drugs in developing countries. Thus, this study aimed to explore the comparative effects of Succimer and D-Penicillamine on acute lead poisoning patients from 2013 to 2018. Me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gholamali, Negar Molavi, Rokhsareh Meamar, Akbar Hasanzadeh, Nastaran Eizadi-Mood
Formato: article
Lenguaje:EN
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Acceso en línea:https://doi.org/10.32598/ijmtfm.v11i3.33474
https://doaj.org/article/744516637ad045ab886a8e157425be1f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:744516637ad045ab886a8e157425be1f
record_format dspace
spelling oai:doaj.org-article:744516637ad045ab886a8e157425be1f2021-11-08T07:04:55ZThe Effects of Succimer and Penicillamine on Acute Lead Poisoning Patientshttps://doi.org/10.32598/ijmtfm.v11i3.334742251-87622251-8770https://doaj.org/article/744516637ad045ab886a8e157425be1f2021-08-01T00:00:00Zhttps://journals.sbmu.ac.ir/ijmtfm/article/view/33474https://doaj.org/toc/2251-8762https://doaj.org/toc/2251-8770Background: Lead poisoning was on the rise in recent years. There exists a lack of easy access to some of the main chelator drugs in developing countries. Thus, this study aimed to explore the comparative effects of Succimer and D-Penicillamine on acute lead poisoning patients from 2013 to 2018. Methods: This descriptive study was conducted in the Clinical Toxicology Department of Khorshid Hospital in Isfahan City, Iran. Adult patients with acute lead poisoning were included in the study. Patients in the 3 treatment groups of D-Penicillamine, D-Penicillamine with succimer, and succimer were compared concerning demographic characteristics as well as clinical and laboratory findings at admission time and two weeks later. Results: In total, 163 patients were evaluated in this research. There was no significant difference between the treatment groups respecting improvement in clinical symptoms. The mean blood lead levels during hospitalization and two weeks after the treatment did not significantly differ between the three groups; however, there was a significant reduction in all study groups after two weeks of treatment (P<0.05). The mean white blood cell count was significantly lower only in the D-Penicillamine group two weeks after hospitalization (P<0.05). In the D-Penicillamine group, the mean platelet, hematocrit, and hemoglobin levels were significantly lower two weeks after hospitalization, although within the healthy range. Conclusion: D-Penicillamine may be an acceptable chelator drug for treating patients with acute lead poisoning, especially in communities without access to drugs, like succimer.Gholamali Negar MolaviRokhsareh MeamarAkbar HasanzadehNastaran Eizadi-MoodShaheed Beheshti University of Medical Sciencesarticled-penicillaminesuccimerpoisoningleadtreatmentMedicine (General)R5-920Toxicology. PoisonsRA1190-1270ENInternational Journal of Medical Toxicology and Forensic Medicine, Vol 11, Iss 3, p 33474 (2021)
institution DOAJ
collection DOAJ
language EN
topic d-penicillamine
succimer
poisoning
lead
treatment
Medicine (General)
R5-920
Toxicology. Poisons
RA1190-1270
spellingShingle d-penicillamine
succimer
poisoning
lead
treatment
Medicine (General)
R5-920
Toxicology. Poisons
RA1190-1270
Gholamali
Negar Molavi
Rokhsareh Meamar
Akbar Hasanzadeh
Nastaran Eizadi-Mood
The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients
description Background: Lead poisoning was on the rise in recent years. There exists a lack of easy access to some of the main chelator drugs in developing countries. Thus, this study aimed to explore the comparative effects of Succimer and D-Penicillamine on acute lead poisoning patients from 2013 to 2018. Methods: This descriptive study was conducted in the Clinical Toxicology Department of Khorshid Hospital in Isfahan City, Iran. Adult patients with acute lead poisoning were included in the study. Patients in the 3 treatment groups of D-Penicillamine, D-Penicillamine with succimer, and succimer were compared concerning demographic characteristics as well as clinical and laboratory findings at admission time and two weeks later. Results: In total, 163 patients were evaluated in this research. There was no significant difference between the treatment groups respecting improvement in clinical symptoms. The mean blood lead levels during hospitalization and two weeks after the treatment did not significantly differ between the three groups; however, there was a significant reduction in all study groups after two weeks of treatment (P<0.05). The mean white blood cell count was significantly lower only in the D-Penicillamine group two weeks after hospitalization (P<0.05). In the D-Penicillamine group, the mean platelet, hematocrit, and hemoglobin levels were significantly lower two weeks after hospitalization, although within the healthy range. Conclusion: D-Penicillamine may be an acceptable chelator drug for treating patients with acute lead poisoning, especially in communities without access to drugs, like succimer.
format article
author Gholamali
Negar Molavi
Rokhsareh Meamar
Akbar Hasanzadeh
Nastaran Eizadi-Mood
author_facet Gholamali
Negar Molavi
Rokhsareh Meamar
Akbar Hasanzadeh
Nastaran Eizadi-Mood
author_sort Gholamali
title The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients
title_short The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients
title_full The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients
title_fullStr The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients
title_full_unstemmed The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients
title_sort effects of succimer and penicillamine on acute lead poisoning patients
publisher Shaheed Beheshti University of Medical Sciences
publishDate 2021
url https://doi.org/10.32598/ijmtfm.v11i3.33474
https://doaj.org/article/744516637ad045ab886a8e157425be1f
work_keys_str_mv AT gholamali theeffectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT negarmolavi theeffectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT rokhsarehmeamar theeffectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT akbarhasanzadeh theeffectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT nastaraneizadimood theeffectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT gholamali effectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT negarmolavi effectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT rokhsarehmeamar effectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT akbarhasanzadeh effectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
AT nastaraneizadimood effectsofsuccimerandpenicillamineonacuteleadpoisoningpatients
_version_ 1718442920329084928